Literature DB >> 23560673

Molecular basis of quantitative fibrinogen disorders in 27 patients from India.

E Sumitha1, G R Jayandharan, N Arora, A Abraham, S David, G S Devi, P Shenbagapriya, S C Nair, B George, V Mathews, M Chandy, A Viswabandya, A Srivastava.   

Abstract

Congenital fibrinogen deficiency is an extremely rare (1:1 000 000) hereditary bleeding disorder caused by defects in genes coding for fibrinogen Aα-, Bβ- and γ-chains, respectively. We report here the molecular basis of fibrinogen deficiency in a large series of patients from India. Twenty-seven patients with clinical features suggestive of fibrinogen deficiency and with prolonged plasma clotting times and low fibrinogen levels were studied. Genomic DNA was screened for mutations in the fibrinogen alpha (FGA), beta (FGB), gamma (FGG) genes by PCR and conformation sensitive gel electrophoresis. Fourteen different disease-causing mutations including frameshifts (51.9%), splice site (22.2%), missense (18.5%) and nonsense mutation (7.4%) were identified in 27 patients. Thirteen of them were novel, including seven frameshifts (fibrinogen Aα: p.Asp296 fs*59, p.Thr466 fs*17 and p.Lys575 fs*74; fibrinogen Bβ: p.Gly414 fs*2 and fibrinogen γ: p.Ser81 fs*5, p.Lys185 fs*13 and p.Asp278_279 fs*17), three splice site mutations (FGA gene c.364+1G>A; c.510+2 T>G; FGB gene c.851+1G>A), two missense substitutions (fibrinogen Bβ: p.Gly288Ser; p.Arg445Thr) and a nonsense mutation in fibrinogen Aα (p.Tyr127*). Two common mutations (FGA: c.364+1G>A, n = 6, FGG: p.Lys185 fs*13, n = 7) affecting 13 patients were identified in this series, suggesting that these mutations could be screened first in Indian patients with fibrinogen deficiency. The molecular data presented here is the largest series of patients with fibrinogen deficiency reported so far, adding significantly to the mutation database of this condition. It also helps create an algorithm for its genetic diagnosis in India.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23560673     DOI: 10.1111/hae.12143

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  8 in total

1.  Identification of novel mutations in patients with fibrinogen disorders and genotype/phenotype correlations.

Authors:  Elena Chinni; Giovanni Tiscia; Giovanni Favuzzi; Filomena Cappucci; Giuseppe Malcangi; Rossana Bagna; Claudia Izzi; Domenica Rizzi; Valerio De Stefano; Elvira Grandone
Journal:  Blood Transfus       Date:  2018-10-08       Impact factor: 3.443

2.  Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.

Authors:  Ran Ni; Miguel A D Neves; Chengliang Wu; Samantha E Cerroni; Matthew J Flick; Heyu Ni; Jeffrey I Weitz; Peter L Gross; Paul Y Kim
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 5.824

Review 3.  Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review.

Authors:  Bipin P Kulkarni; Sona B Nair; Manasi Vijapurkar; Leenam Mota; Sharda Shanbhag; Shehnaz Ali; Shrimati D Shetty; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

4.  Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.

Authors:  Arshi Naz; Arijit Biswas; Tehmina Nafees Khan; Anne Goodeve; Nisar Ahmed; Nazish Saqlain; Shariq Ahmed; Ikram Din Ujjan; Tahir S Shamsi; Johannes Oldenburg
Journal:  Thromb J       Date:  2017-09-12

Review 5.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 6.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

Review 7.  Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.

Authors:  Zofie Sovova; Klara Pecankova; Pavel Majek; Jiri Suttnar
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

8.  Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder.

Authors:  Eliška Ceznerová; Jiřina Kaufmanová; Žofie Sovová; Jana Štikarová; Jan Loužil; Roman Kotlín; Jiří Suttnar
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.